2009. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929): 930-935. A computational analysis identified TET proteins as mammalian homologs of the trypanosome J-binding proteins, JBP1 and JBP2 that have been proposed to oxidize the 5-methyl group of thymine. We tested the hypothesis that TET proteins modify 5-methylcytosine in DNA. Here we show that TET1, previously characterized as a fusion partner of the MLL gene in acute myeloid leukemia, is a 2oxoglutarate (2OG)-and Fe(II)-dependent oxygenase that catalyzes the conversion of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro. Expression of TET1 in HEK293 cells led to a decrease in 5mC as judged by immunocytochemistry, with concomitant appearance of a novel nucleotide identified by mass spectrometry as hmC. The catalytic domain of TET1 converted 5mC to hmC in vitro, whereas a variant with substitutions in residues predicted to bind the catalytic Fe(II) did not generate hmC. hmC can be detected in the genome of mouse ES cells and both TET1 levels and hmC levels decline when ES cells are differentiated. RNA-interference-mediated depletion of TET1 results in a decrease in hmC levels in ES cells. Our results suggest that hmC is a normal constituent of mammalian DNA, and identify TET1 as an enzyme with a potential role in epigenetic regulation through modification of 5mC.
Introduction 5-methylcytosine (5mC) is a minor base in mammalian DNA. It constitutes ~1% of all DNA bases and is found almost exclusively as symmetrical methylation of the dinucleotide CpG (1). The majority of methylated CpG is found in repetitive DNA elements, suggesting that cytosine methylation evolved as a defense against transposons and other parasitic elements in DNA (2, 3) . Indeed, loss of the DNA methyltransferase Dnmt1 in mice results in reactivation of a class of retrotransposons in somatic cells (4) . Methylated CpGs are mutagenic; the modified cytosine is prone to deamination to yield thymine, thus generating T:G mismatches which if unrepaired result in C to T transitions. This mechanism has been proposed to effect a slow but progressive inactivation of retrotransposons in the genome (2) .
Methylation patterns in mammals are remarkably dynamic during early embryogenesis, when CpG methylation is essential for establishing X-inactivation and the asymmetric expression of imprinted genes (5, 6) . In somatic cells, CpG islands in genes that are not expressed are often highly methylated. DNA methylation enables the recruitment of methyl-CpG binding proteins such as MeCP2 and Kaiso; these in turn recruit histone deacetylases and other chromatin-modifying complexes that create a repressed chromatin environment, ultimately resulting in chromatin compaction and gene silencing (7, 8) . In addition, CpG methylation may directly interfere with the binding of certain transcriptional regulators to their cognate DNA sequences (9) , as best shown for the insulator-binding protein CTCF which controls the reciprocal expression of the imprinted genes Igf2 and H19 on paternal and maternal chromosomes respectively (10) . DNA methylation patterns are highly dysregulated in cancer, and changes in methylation status have been postulated to inactivate tumor suppressors and activate oncogenes, thus contributing to tumorigenesis (11) .
The enzymes that methylate DNA in mammals have been thoroughly characterized. Two de novo methyltransferases, DNMT3A and DNMT3B, symmetrically methylate unmethylated DNA (12) , whereas the maintenance methyltransferase, DNMT1, maintains the established patterns of DNA methylation by methylating CpGs during DNA replication (3, 10) . Preventing maintenance methylation through successive replication cycles progressively dilutes the methyl mark and results in "passive" DNA demethylation, a process well-documented to occur in differentiating cells (13) . An "active" enzymatic mechanism of DNA demethylation has also been postulated; the most convincing example involves the genome-wide demethylation of the paternal genome that occurs shortly after fertilization, independently of DNA replication (14) (15) (16) . Potential mechanisms for active demethylation include (i) a thermodynamically unfavorable cleavage of the carbon-carbon bond linking the methyl group to the pyrimidine, resulting in release of the methyl moiety; and (ii) a repair-like process in which the methylated base or nucleotide is excised and the lesion is then repaired to replace the original 5mC with an unmethylated C (reviewed in (5, 17) ). This latter mechanism occurs in plants, where DEMETER, a bifunctional glycosylase restricted to flowering plants, cleaves the glycosidic bond of 5mC and stimulates insertion of an unmethylated C through base-excision repair (18) . A variety of candidate mammalian demethylase activities have been described, but unfortunately, none of these reports have been confirmed by other laboratories (reviewed in (19) (20) (21) ).
In trypanosomes, a potential analog of 5-methylcytosine is a modified version of thymine called base J (β-D-glucosyl hydroxymethyluracil), which appears to be derived by hydroxylation of thymine followed by glucosylation (22) . Base J is thought to play an important role in silencing gene transcription. It is present in silenced copies of the genes encoding the variable surface glycoprotein (VSG) responsible for antigenic variation in the host, but is absent from the single expressed copy (23, 24) . A J-binding protein, JBP1, and a homolog, JBP2, were identified biochemically and through homology searches respectively (22, 24) . JBP1 and JBP2 are enzymes of the 2OG and Fe(II)-dependent oxygenase superfamily (22) , and mutations of the predicted Fe(II)-and 2OG-coordinating residues in JBP1 and JBP2 lead to decreased levels of base J in trypanosome and Leishmania DNA. Based on these data, the authors proposed that JBP1 and JBP2 oxidize the 5-methyl group of thymine in the first step of J biosynthesis (22, 25, 26) We speculated that homologs of JBP1 and JBP2 might be generally involved in modification of 5-methylpyrimidines, including thymine and 5-methylcytosine.
Computational analysis identified the TET family of proteins (TET1, TET2 and TET3) as likely homologs with predicted 2OG and Fe(II)-dependent oxygenase activity. Here we show that TET1 catalyzes the conversion of 5mC to hmC both in cells and in vitro.
Moreover, we demonstrate that hmC is present in the genome of undifferentiated ES cells, but is not detectable in genomic DNA of two differentiated cell types, previously-activated human T cells and mouse dendritic cells. TET1 and hmC levels diminish in parallel when ES cell differentiation is induced by withdrawal of the cytokine LIF, and RNAi-mediated depletion of TET1 in ES cells results in decreased hmC. These studies define a new class of enzymes that catalyze a new modification of DNA, and modify our perception of how DNA methylation status may be regulated in mammalian cells.
RESULTS

Identification of a novel family of 2OG-Fe(II) oxygenases with predicted 5methylpyrimidine oxidase activity
To identify candidate enzymes that catalyze the oxidative modification of 5methylcytosine, we created a position-specific score matrix (profile) of known 2OG-Fe(II) oxygenases that included the predicted oxygenase domains of JBP1 and JBP2 (Suppl. Fig. S1 ). We used this profile to conduct a systematic search of the non-redundant database using the PSI-BLAST program (27) . This search recovered homologous domains in the gp2 proteins from the mycobacteriophages Cooper and Nigel and a related prophage from the Frankia alni genome (e<10 -4 ). We then generated a new profile which included the gp2 protein sequences, and performed a second search of the protein sequence database of microbes from environmental samples. This search detected numerous homologous proteins potentially derived from uncultured marine phages and prophages. A further search of the non-redundant database, with the newly-detected proteins from the environmental sequences added to the profile, recovered homologous regions in the three paralogous human oncogenes TET1 (CXXC6), TET2 and TET3 and their orthologs found throughout metazoa (e<10 -5 ). Homologous domains were also found in fungi and algae. In PSI-BLAST searches, these groups of homologous domains consistently recovered each other prior to recovering any other member of the 2OG-Fe(II) oxygenase superfamily, suggesting that they constitute a distinct family (LM Iyer, L Aravind, manuscript in preparation).
To confirm the relationship of the newly-identified proteins (hereafter referred to as the TET/JBP family; see legend to Fig. 1 ) with classical 2OG-Fe(II) oxygenases, we prepared a multiple alignment of their shared conserved domains and used this to generate a hidden markov model (HMM). A profile-profile comparison of this HMM against a library of HMM's generated for all structurally-characterized domains from the Protein Database (PDB) with the HHpred program (28) resulted in recovery of prolyl hydroxylase (e<10 -12 ), a canonical member of the 2OG-Fe(II) oxygenase superfamily, as the best hit. Secondary structure predictions suggested the existence of an N-terminal α-helix followed by a continuous series of β-strands, typical of the double-stranded β-helix (DSBH) fold of the 2OG-Fe(II) oxygenases (29) (Fig. 1A, bottom) . A multiple sequence alignment ( Fig. 1A) further showed that the new TET/JBP family displayed all of the typical features of 2OG-Fe(II) oxygenases including: (i) the HxD signature, just downstream of an N terminal βstrand which chelates Fe(II) (x is any amino acid); (ii) a small residue, usually glycine, at the beginning of the strand immediately downstream of the HxD motif, which helps in positioning the active site arginine; (iii) the Hxs motif (where s is a small residue) in the Cterminal part, in which the H chelates the Fe(II) and the small residue helps in binding the 2-oxo acid; (iv) the Rx 5 a signature (where a is an aromatic residue) downstream of the above motif -the R in this motif forms a salt bridge with the 2-oxo acid and the aromatic residue helps position the first metal-chelating histidine (the key residues are marked with asterisks in Fig 1A) . These observations strongly suggested that members of the TET/JBP family, including TET1, 2 and 3, are catalytically-active 2OG-Fe(II) oxygenases.
Additionally, the metazoan TET proteins contain a unique conserved cysteine-rich region, contiguous with the N-terminus of the DSBH region, which possesses at least eight conserved cysteines and one histidine that are likely to comprise a binuclear metal cluster ( Fig. 1A, top) . Vertebrate TET1 and TET3, and their orthologs from all otheranimals, also possess a CXXC domain, a binuclear Zn-chelating domain with eight conserved cysteines and one histidine, located N-terminal to the 2OG-Fe(II) oxygenase domain (shown schematically for TET1 in Fig. 1B ). Analysis of the architectures of CXXC domain proteins suggests that the CXXC domain is an accessory DNA-binding domain, that tends to be combined in the same polypeptide with a variety of domains that possess diverse chromatin-modifying and modification recognition activities. The CXXC domain is found in several chromatin-associated proteins, including the methyl-DNA-binding protein MBD1, the histone methyltransferase MLL, the DNA methyltransferase DNMT1 (30) and the lysine demethylases KDM2A (JHDM1A/ FBXL11) and KDM2B (JHDM1B/FBLX10, which also contains a ubiquitin E3 ligase domain) (31) , and in certain cases has been shown to discriminate between methylated and unmethylated DNA (32) .
Taken together, the contextual information gleaned from these domain architectures and from gene neighborhoods in the bacteriophage members (Supplementary Information and LM Iyer, L Aravind, manuscript in preparation) supported a conserved DNA modification function for the entire TET/ JBP family, namely oxidation of 5-methyl-pyrimidines. In this study we tested the specific hypothesis that TET proteins might operate on 5mC to catalyze oxidation or oxidative removal of the methyl group, focusing on TET1 as a mammalian example of the TET/JBP family.
Cells overexpressing TET1 show decreased staining for 5-methylcytosine
To determine whether increasing the amount of TET1 expression would alter the global levels of 5mC in cells, we expressed HA-tagged full-length TET1 in HEK293 cells. Two days after transfection, cells were fixed, doubly stained with antibodies specific for 5mC and for the HA epitope, and processed for immunocytochemistry ( Fig. 2A) . To quantify the relation between HA (TET1) and 5mC staining at a single-cell level in each cell in a given field, the intensities of HA and 5mC staining were measured in each pixel within an area defined as the cell nucleus by DAPI staining (CellProfiler TM image analysis software, Suppl. Fig. S2 ). The mean pixel intensity for each cell analyzed is represented by a dot in Mock-transfected cells showed substantial variation in 5mC staining intensity ( Fig. 2A , top panel), either because 5mC levels vary from cell to cell or because the accessibility of 5mC to the antibody differs among cells due to technical considerations (e.g. incomplete denaturation of DNA). This spread in staining intensity is obvious in Fig. 2B , in which mock-transfected cells are represented by blue dots and enclosed in a dotted oval. In cells transfected with TET1, there was a strong visual correlation of HA positivity with decreased staining for 5mC ( Fig. 2A, middle panel) . The population of HA-low cells, presumed to be untransfected, showed a spread of 5mC staining intensity similar to that of the mock-transfected population ( Fig. 2B , left panel, note overlapping red and blue dots at low HA intensities), whereas the productively transfected (HA-high) cells showed a clear decrease in 5mC staining intensity ( Fig. 2B , left panel, note uniformly low 5mC staining intensity in the red HA-high dots).
In addition to wild-type TET1, we tested the effect of a mutant TET1 bearing H1671Y, D1673A substitutions predicted to impair Fe(II) binding. Cells expressing this mutant protein did not show decreased staining for 5mC; rather, both visual and quantitative analysis indicated that cells expressing high levels of HA could also display high levels of 5mC staining ( Fig These results are consistent with the hypothesis that the H1671Y, D1673A mutations compromise a biological function of TET1.
An unidentified nucleotide derived from 5mC is present in HEK293 cells expressing TET1
To determine more quantitatively whether TET1 overexpression affects the intracellular levels of 5mC, we used an approach that allowed us to measure the ratio of 5mC to C at a subset of genomic CpG sites (those present in sequences recognized by the methylationinsensitive restriction enzyme MspI) (33) . For these experiments we used full-length TET1 (TET1-FL) as well as the predicted catalytic domain of TET1 (TET1-CD, comprising the Cys-rich (C) and DSBH (D) regions; see Fig. 1B ). HEK293 cells were transiently transfected with vectors in which expression of wild-type or mutant TET1 proteins was coupled to expression of human CD25, from an internal ribosome entry site (IRES).
Control cells (mock) were transiently transfected with a corresponding empty vector that drove expression of CD25 alone. Forty-eight hours after transfection, CD25-expressing cells were purified using magnetic beads, and genomic DNA was isolated and digested with MspI. MspI cleaves DNA at the recognition site C^CGG regardless of whether or not the second C is methylated, producing cleavage products whose 5' ends derive from the dinucleotide CpG and contain either C or 5mC. The 5' phosphates were removed by treatment with calf intestinal phosphatase (CIP) and the fragments were end-labeled with T4 PNK and [γ- 32 To confirm that the unidentified species was not an artifact of MspI digestion, we analyzed genomic levels of 5mC using Taq α I, a methylation-insensitive enzyme that cuts at T^CGA, and therefore, like MspI, produces DNA fragments whose 5' ends contain C or 5mC from the dinucleotide CpG. Again, the unidentified species was observed by TLC in Taq α Idigested DNA from cells expressing wildtype, but not mutant, TET1-CD ( Fig. 3E ), and the appearance of this species was associated with a corresponding decrease in abundance of 5m-dCMP ( Fig. 3F ). In all experiments, expression of wild-type TET1-CD correlated with a small but significant increase in the abundance of dCMP ( Fig. 3C , F). Together these results demonstrate that expression of wild-type TET1 in HEK293 cells correlates with a decrease in the abundance of 5mC as assayed by immunocytochemistry and TLC, and with the concomitant appearance of a new nucleotide species as shown in a quantitative assay involving restriction enzyme digestion and TLC.
Cells overexpressing TET1 contain increased levels of hmC in their genome
Because many members of the 2OG and Fe(II)-dependent oxygenase superfamily are hydroxylases, we hypothesized that the unidentified species observed in TET1-expressing cells was hmC, and that TET1 hydroxylates the 5-methyl moiety of 5mC, converting it to hmC. These hypotheses are consistent with the slower migration of the unidentified species on cellulose TLC plates relative to 5m-dCMP and dCMP (Figs. 3B, E). Since hmC and its glucosylated derivatives are known to replace cytosine in the genome of T-even phages (34) we used hm-dCMP from unglucosylated T4 phage DNA as an authentic source of hm-dCMP. Unglucosylated T4 phage (T4*) DNA was produced by growing T4 phage in E.coli ER1656, a strain deficient in the glucose donor molecule, UDP-glucose.
Genomic DNA from T4* phage was digested with Taq α I, end-labeled, hydrolyzed and resolved using TLC. These experiments confirmed that the novel nucleotide generated in cells expressing TET1-CD migrated in a TLC assay similarly to authentic hm-dCMP from unglucosylated T4 DNA (Fig. 4A ).
We used a mass spectrometry-based approach to identify the novel nucleotide. Genomic DNA was prepared from unsorted HEK293 cells ( Fig. 4A ) overexpressing wildtype or mutant TET1-CD and digested to 5' dNMPs. Following semi-preparative-scale TLC, the unknown species migrating with an Rf value of ~0.29 was extracted from the TLC plates with water and the extracts were analyzed by high-resolution mass spectrometry (MS).
Although several species showed a ~2-fold difference in their abundance in DNA from cells expressing wild-type compared to mutant TET1-CD, most likely because of variation in the amount of resin excised from the respective TLC plates, a singly-charged species with an observed m/z of 336.0582, consistent with a molecular formula of C 10 implying that in cells expressing wild-type but not mutant TET1, a significant proportion of 5mC is oxidized to hmC.
TET1 hydroxylates 5mC in vitro
To determine if TET1 was directly responsible for hmC production in transfected cells, we expressed Flag-HA-tagged wildtype and mutant TET1-CD in Sf9 insect cells, and purified the recombinant protein to near homogeneity (Suppl. Fig. S4A ). The ability of the purified proteins to catalyze 5mC to hmC conversion was tested by incubating them with double-stranded DNA oligonucleotides containing a fully methylated Taq α I recognition site.
Conversion of 5mC to hmC was monitored by TLC ( Fig. 5A ). Wild-type TET1-CD, but not the H1671Y, D1673A mutant, catalyzed robust conversion of 5mC to hmC (Fig 5A, compare lanes 2 and 6). We confirmed that TET1 uses Fe(II) and 2OG as cofactors by independently omitting each factor from the enzymatic reactions. TET1 displayed an absolute requirement for both cofactors (Fig 5A, compare lane 2 with lanes 3 and 5) .
Although some 2OG-and Fe(II)-dependent oxygenases show enhanced activity in the presence of ascorbate (35) , we saw no decrease in TET1-CD enzymatic activity in the absence of ascorbate. This is likely due to the fact that DTT, which was included in the reaction buffer to counteract the strong tendency of TET1-CD to oxidize (Suppl. Fig S4A- C), is able to play a similar role to ascorbate in reducing inactive Fe(III) to Fe(II) thereby protecting the enzyme from oxidative inactivation (Fig. 5A, compare lanes 2 and 4) (36, 37) . The results are quantified in Fig. 5B .
We used high-resolution mass spectrometry to demonstrate, as before, that a singlycharged species at m/z of 336.0582 was the only species at Rf ~0.29 that differed significantly (35-fold) in abundance when comparing substrates incubated with wild-type and mutant proteins ( Fig. 5C ). MS-MS experiments at various collision energies showed, as before, that the fragmentation pattern of the species produced by recombinant TET1-CD was identical to that of authentic hm-dCMP derived from unglucosylated T4 phage ( Fig. 5D and data not shown). Under the conditions of our assay, recombinant TET1-CD hydroxylated 5mC not only in fully-methylated, but also in hemi-methylated oligonucleotide substrates ( Fig. 5E ).
Since TET1 was identified as a homolog of the putative thymine hydroxylases JBP1 and JBP2, we tested the ability of TET1-CD to hydroxylate thymine in vitro. Recombinant TET1-CD was incubated with double-stranded DNA oligonucleotides containing a SalI recognition site (G^TCGAC). Conversion of thymine to hmU was either very inefficient or did not occur (Suppl. Fig. S5 ), showing specificity of TET1 for 5mC and not for thymine.
Together these data demonstrate that TET1 is a member of the 2OG and Fe(II)dependent oxygenase superfamily with the ability to oxidize 5mC to hmC in doublestranded DNA.
hmC is present in ES cell DNA and its abundance decreases upon differentiation or TET1 depletion
We next asked whether hmC was a normal constituent of mammalian DNA. Using the TLC assay, we compared hmC levels in the sequence CCGG (i.e. in MspI cleavage sites) in previously-activated human T cells, mouse dendritic cells, and ES cells. We observed a clear spot corresponding to labelled hmC only in ES cells ( Fig. 6A ), suggesting an association of hmC with the pluripotent rather than the differentiated state. Quantification of multiple experiments indicates that hmC and 5mC constitute ~4% and 55-60% respectively of all cytosine species in MspI cleavage sites (CCGG) in ES cells (Fig. 6A ).
To examine this relation further, we asked whether TET1 and hmC levels were altered when ES cells were differentiated by removal of the cytokine LIF from culture media. Similarly, RNAi-mediated depletion of endogenous TET1 with two different siRNAs resulted in an 83-85% decrease in TET1 mRNA levels and a corresponding ~38% decrease in hmC levels ( Fig. 6D, E) . Again, the discrepancy is likely due to the presence of TET2 and TET3, which are both expressed in ES cells. These data strongly support the hypothesis that TET1, and potentially other TET family members, are responsible for hmC generation in ES cells under physiological conditions.
Discussion
We have identified TET1, a member of the TET/JBP family of enzymes, as a 2OG and Fe(II)-dependent enzyme capable of oxidizing 5mC to hmC both in cells and in vitro.
Members of the TET subfamily (TET1, TET2 and TET3) are conserved in jawed vertebrates and are broadly expressed in many cell types (30) . All three paralogs are likely to possess catalytic activity, as the residues predicted to be necessary for activity are fully conserved.
hmC is a normal constituent of mammalian DNA, at least in certain cell types. Of the limited number of cell types that we analyzed, only ES cells possessed readily detectable levels of hmC in MspI cleavage sites (CCGG). In contrast, hmC was almost undetectable in HEK293 cells and two differentiated primary cell types, dendritic cells and previouslyactivated T cells. Consistent with our finding that overexpressed and recombinant TET1 catalyzed the conversion of 5mC to hmC in HEK293 cells and in vitro respectively, RNAimediated depletion of TET1 in ES cells led to a perceptible loss of hmC.
Notably, ES cells induced to differentiate in response to LIF withdrawal showed parallel decreases in TET1 mRNA expression and hmC levels in genomic DNA, suggesting a possible relation between hmC and the pluripotent state of ES cells. To explore this hypothesis in more detail, it will be useful to ask whether hmC and TET proteins localize to specific regions of ES cell DNA -for instance, to genes that are involved in maintaining pluripotency or that are poised to be expressed upon differentiation. hmC may not be confined to CpGs: nearest-neighbour analyses have shown that whereas somatic tissues have negligible non-CpG methylation, 15-20% of total 5mC in ES cells is present in CpT, CpA and (to a minor extent) CpC sequences (38) .
What are the biological functions and fate of hmC? Figure 7 summarizes some speculations. An attractive hypothesis is that hmC (which is a stable base in the genome of T-even phages (34) influences chromatin structure and local transcriptional activity by recruiting proteins that selectively bind to hmC (Fig. 7B) . Conversely, the hmC modification might exclude methyl-CpG-binding proteins (MBPs) that normally recognize 5mC, thus displacing chromatin-modifying complexes that are recruited by MBPs (7, 8) .
In support of this latter scenario, it has already been demonstrated that the methyl-binding protein MeCP2 does not recognize hmC (39) .
The stability of hmC contrasts with the well-documented instability of N-linked hydroxymethyl adducts generated by the DNA repair enzymes AlkB and the JmjC domaincontaining histone demethylases, which are also members of the 2OG and Fe(II)dependent oxygenase superfamily. These nitrogen-linked adducts spontaneously resolve, yielding the unmethylated amino group and formaldehyde (36) ; in contrast, oxidation of carbon-linked methyl groups by JBP1/2 and thymine hydroxylase does not result in removal of the methyl adduct via oxidation (22, 25, 40) . This difference, which is due to the fact that carbon is a much poorer leaving group than nitrogen, explains our ability to detect hmC in genomic DNA. Nevertheless, hmC has been shown to convert to cytosine through loss of formaldehyde in photo-oxidation experiments (41) and at high pH (42, 43) , leaving open the possibility that hmC could convert to cytosine under certain conditions in cells (Fig. 7A ).
Another possibility is that hmC is an intermediate in a pathway of passive (replicationdependent) DNA demethylation (Fig. 7A, B) . The presence of hmC on one strand of the dinucleotide CpG has been shown to prevent DNMT1 from methylating its target C in the opposite strand (44) . Thus the small but reproducible increase in the relative abundance of unmethylated cytosine at C^CGG and T^CGA sites, observed within two days of expressing TET1-CD in HEK293 cells (Fig. 3C, F) , is consistent with a model in which demethylation of 5mC proceeds via hmC. Even a minor reduction in the fidelity of maintenance methylation would be expected to result in an exponential decrease in CpG methylation over the course of many cell cycles. It will be of interest to test if the SAD (SRA) domain protein UHRF1, the DNMT1 partner protein that is responsible for its high selectivity for hemimethylated CpGs (45) , is also less capable of recognizing hemimodified hmCpG.
Alternatively, the presence of hmC might be sensed by specific DNA repair mechanisms that replace hmC with C, thus leading to "active" demethylation of DNA (Fig. 7) . In fact, bovine thymus extracts have been reported to contain a glycosylase activity specific for hmC (46) , but this activity has not been further characterized. Moreover, several DNA glycosylases, including TDG and MBD4, have been implicated in DNA demethylation, although none of them has shown a convincing activity on 5mC using in vitro enzymatic assays (47) (48) (49) (50) . Finally, cytosine deamination has also been implicated in demethylation of DNA (49) (50) (51) . In this context, it is conceivable that deamination of hmC, which would result in its conversion to hmU, might be involved in the conversion of hmC into a substrate for repair enzymes. In support of this hypothesis, high levels of HmU:G glycosylase activity have been reported in fibroblast extracts (52) . With the description of this new derivative of 5mC, it will be important to reexamine the specificity of known DNA glycosylases and deaminases for DNA containing hmC and its potential derivatives.
Why has hmC been overlooked as a normal constituent of mammalian DNA? With the exception of two papers that reported high levels of hmC in genomic DNA isolated using unconventional but not standard methods (53) , most previous studies describe hmC as a rare base that is a probable oxidation product of 5mC (44, 54) . One reason that hmC may have been missed is that it might be present at detectable levels only in specific cell types (ES cells and not differentiated cells). Another factor may be the relatively low abundance of hmC. In ES cells, hmC is ~4% of all cytosine species in CpG dinucleotides located in MspI cleavage sites (CCGG) (Fig. 6C, E) . CpG is ~0.8% of all dinucleotides in the mouse genome (55), thus hmC constitutes ~0.032% of all bases or ~1 in every 3000 nucleotides.
For comparison, 5mC is 55-60% of all cytosines in CpG dinucleotides in MspI cleavage sites (Fig. 6A) , about 14-fold higher than hmC. A more trivial explanation is that some TLC running buffers do not resolve hmC from C (53) . We were fortunate that our experimental design led us to focus on areas of the genome containing CpG dinucleotides (and hence enriched for 5mC), and that our TLC running conditions could distinguish hmC.
A full appreciation of the biological significance of hmC will depend heavily on the development of tools that allow hmC, 5mC and C to be distinguished unequivocally. We show here that two of the three most commonly used techniques do not meet this criterion. A widely-used mouse monoclonal antibody to 5mC apparently does not recognize hmC by immunocytochemistry ( Fig. 2A) , thus it will be important to reevaluate previous reports of DNA demethylation based solely on the use of this antibody. Similarly, the methylation-sensitive restriction enzyme, HpaII, fails to cut hmC (Fig. 3D ) as previously reported (56), raising the possibility that in some instances hmC-modified DNA was incorrectly judged to be methylated. Another methylation-sensitive restriction enzyme, McrBC, is already known to cleave 5mC-and hmC-containing DNA equivalently (57) , and therefore also does not allow these two nucleotides to be distinguished. It is yet to be determined how bisulfite modification analysis interprets the presence of hmC in DNA. Treatment of DNA with sodium bisulfite promotes the spontaneous deamination of cytosine to uracil, while leaving 5mC unaffected; amplification of the sequence of interest followed by sequencing allows the precise methylation patterns at a given sequence to be determined (58) . It is known that bisulfite reacts rapidly with hmC at the C5 to form a stable cytosine 5-methylenesulfonate adduct, which is not readily deaminated (59) . This substituted species, which is expected to form base pairs similar to those formed by cytosine, could be read by polymerases as C during the amplification steps, resulting in the sequence being interpreted as containing 5mC. Alternatively, polymerases may not copy cytosine 5-methylenesulfonate efficiently, in which case the DNA containing this adduct would not be amplified effectively and the sequence containing the original hmC modification would be underrepresented in the amplified DNA.
Notably, disruptions of the TET1 and TET2 genetic loci have been reported in association with hematologic malignancies. A fusion of TET1 with the histone methyltransferase, MLL, has been identified in at least two cases of acute myeloid leukemia (AML) associated with t(10;11)(q22;q23) translocation (30, 60) . Homozygous null mutations and chromosomal deletions involving the TET2 locus have been found in AML and myeloproliferative disorders, suggesting a tumor suppressor function for TET2 (61, 62) . It will be interesting to test the involvement of TET proteins and hmC in oncogenic transformation and malignant progression. Flag-HA-TET1-CD in a buffer containing 1 mM 2OG, 2 mM ascorbic acid, 75 µM Fe(II) for 5 hours at 37 C (1:10 enzyme to substrate ratio). Recovered oligonucleotides were digested with Taq α I or SalI, end-labeled, hydrolyzed to dNMP's and resolved using TLC.
TET1-CD is able to hydroxylate 5mC, but is not able to act on thymine in the context of a 
Methods
Computational and bioinformatic analyses. The non-redundant (NR) database of protein sequences (National Center for Biotechnology Information, NIH, Bethesda) was searched using the PSI-BLAST programs (3) . Profile searches using the PSI-BLAST program were conducted either with a single sequence or a sequence with a PSSM used as the query, with a profile inclusion expectation (E) value threshold of 0.01, and were iterated until convergence (3) . For all compositionally biased queries the correction using composition-based statistics was used in the PSI-BLAST searches (4) . Multiple alignments were constructed using the Kalign program (5), followed by manual correction based on the PSI-BLAST results. The multiple alignment was used to create a HMM using the Hmmbuild program of the HMMER package (6) . It was then optimized with Hmmcaliberate and the resulting profile was used to search a database of completely sequenced genomes using the Hmmsearch program of the HMMER package (6) . Profile-profile searches were performed using the HHpred program (7, 8) . The JPRED program (9) and the COILS program were used to predict secondary structure.
Globular domains were predicted using the SEG program with the following parameters:
window size 40, trigger complexity=3.4; extension complexity=3.75 (10) .
The Swiss-PDB viewer (11) and Pymol programs were used to carry out manipulations of PDB files. Reconstruction of exon-intron boundaries was done using the NCBI Splign program with the tblastn searches against chromosomes as a guide. Gene neighborhoods were determined using a custom script that uses completely sequenced genomes or whole genome shot gun sequences to derive a table of gene neighbors centered on a query gene. Then the BLASTCLUST program is used to cluster the products in the neighborhood and establish conserved co-occurring genes. These under the three excitation wavelengths respectively for DAPI, GFP (detection of HA) and
Cy3 (detection of 5mC). Nuclear outlines were profiled based on the DAPI staining, with a secondary module included to expand the nuclear outlines by another 2 pixels (denoted as "expanded nuclei") to account for HA staining at nuclear boundaries.
Clustered cells and cells at the edge of fields were excluded. Staining intensities of HA and 5mC within individual cells profiled were measured as mean pixel intensities of GFP and Cy3 signals, respectively, within the "expanded nuclei" and original nuclei profiles, respectively. The raw data were exported on Excel spreadsheets and plotted as dot plots of 5mC mean pixel intensities against HA mean pixel intensities for each transfection sample.
Transfection and Sorting of HEK293T cells expressing hCD25 HEK293T cells were
transfected with TET1-CD-IRES-CD25-pEF1 vectors using TransIT transfection reagent (MIrius). After 48 hours, 30 x 10 6 cells were stained with anti-hCD25-PE antibody
